z-logo
open-access-imgOpen Access
Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA2 Receptor
Author(s) -
Renukadevi Patil,
James I. Fells,
Erzsébet Szabó,
Keng G. Lim,
Derek D. Norman,
Andrea Balogh,
Shivaputra A. Patil,
Jur Strobos,
Duane D. Miller,
Gábor Tigyi
Publication year - 2014
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/jm5007116
Subject(s) - chemistry , lysophosphatidic acid , g protein coupled receptor , agonist , benzoic acid , docking (animal) , stereochemistry , receptor , ligand (biochemistry) , mediator , biochemistry , pharmacology , microbiology and biotechnology , biology , medicine , nursing
Lysophosphatidic acid (LPA) is a growth factor-like mediator and a ligand for multiple GPCR. The LPA2 GPCR mediates antiapoptotic and mucosal barrier-protective effects in the gut. We synthesized sulfamoyl benzoic acid (SBA) analogues that are the first specific agonists of LPA2, some with subnanomolar activity. We developed an experimental SAR that is supported and rationalized by computational docking analysis of the SBA compounds into the LPA2 ligand-binding pocket.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom